Utilization of palliative care consultations in pediatric oncology phase I clinical trials

Andrea Cuviello, Renee Boss, Nirali Shah, Haven Battles, Andrea Beri, Lori Wiener

Research output: Contribution to journalArticle

Abstract

Pediatric phase I clinical oncology trials represent a unique cohort of patients who have not responded to standard therapies and remain highly vulnerable to treatment toxicity and/or disease burden. Incorporating a palliative care consultation into the care plan for those with relapsed/refractory cancer where chance of cure is limited is generally recommended. A retrospective chart review of pediatric phase I trials revealed that palliative care was consulted in <20% of patients, most often for symptom management. Efforts to increase the use of palliative services in this population may enhance quality of life for children and families enrolled in phase I studies.

Original languageEnglish (US)
Article numbere27771
JournalPediatric Blood and Cancer
Volume66
Issue number8
DOIs
StatePublished - Aug 2019

Keywords

  • palliative care
  • pediatric oncology
  • phase I trial
  • quality of life
  • symptom management

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Utilization of palliative care consultations in pediatric oncology phase I clinical trials'. Together they form a unique fingerprint.

  • Cite this